Literature DB >> 21422520

Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration.

Britta Schürmann1, Birgitt Wiese, Horst Bickel, Siegfried Weyerer, Steffi G Riedel-Heller, Michael Pentzek, Cadja Bachmann, Julie Williams, Hendrik van den Bussche, Wolfgang Maier, Frank Jessen.   

Abstract

A variant within the clusterin gene has been recently associated with increased risk for Alzheimer's disease (AD) in genome wide association studies. Here we tested the association of the respective single nucleotide polymorphisms (rs11136000) with plasma concentration of clusterin in 67 AD subjects and 191 cognitively unimpaired elderly individuals. We observed an association of the rs11136000 AD-risk variant with low clusterin plasma levels in an allele-dose dependent manner in the healthy individuals (p = 0.011). This effect was numerically also present in the AD patients. We conclude that the rs11136000 AD-risk variant is associated with low clusterin plasma levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422520     DOI: 10.3233/JAD-2011-110251

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  25 in total

Review 1.  HDL-cholesterol and apolipoproteins in relation to dementia.

Authors:  Manja Koch; Majken K Jensen
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

Review 2.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

Review 3.  [Search for risk genes in Alzheimer's disease].

Authors:  I Karaca; H Wagner; A Ramirez
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

Review 4.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

5.  Association between clusterin concentration and dementia: a systematic review and meta-analysis.

Authors:  Caiping Yang; Hai Wang; Chaojiu Li; Huiyan Niu; Shunkui Luo; Xingzhi Guo
Journal:  Metab Brain Dis       Date:  2018-10-05       Impact factor: 3.584

Review 6.  Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Authors:  Celeste M Karch; Alison M Goate
Journal:  Biol Psychiatry       Date:  2014-05-17       Impact factor: 13.382

7.  No diagnostic value of plasma clusterin in Alzheimer's disease.

Authors:  Edina Silajdžić; Lennart Minthon; Maria Björkqvist; Oskar Hansson
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

Review 8.  Dendritic Spines: Mediators of Cognitive Resilience in Aging and Alzheimer's Disease.

Authors:  Courtney K Walker; Jeremy H Herskowitz
Journal:  Neuroscientist       Date:  2020-08-19       Impact factor: 7.235

9.  Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.

Authors:  Ayodeji A Asuni; Bryony Gray; Joanne Bailey; Paul Skipp; V Hugh Perry; Vincent O'Connor
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

Review 10.  Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems.

Authors:  Douglas Galasko; Todd E Golde
Journal:  Alzheimers Res Ther       Date:  2013-03-07       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.